Cargando…

Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()

Detalles Bibliográficos
Autor principal: Vigorito, Afonso Celso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119658/
https://www.ncbi.nlm.nih.gov/pubmed/27863752
http://dx.doi.org/10.1016/j.bjhh.2016.07.006
_version_ 1782469104853057536
author Vigorito, Afonso Celso
author_facet Vigorito, Afonso Celso
author_sort Vigorito, Afonso Celso
collection PubMed
description
format Online
Article
Text
id pubmed-5119658
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-51196582016-11-28 Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?() Vigorito, Afonso Celso Rev Bras Hematol Hemoter Scientific Comment Sociedade Brasileira de Hematologia e Hemoterapia 2016 2016-09-09 /pmc/articles/PMC5119658/ /pubmed/27863752 http://dx.doi.org/10.1016/j.bjhh.2016.07.006 Text en © 2016 Associaç˜ao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Scientific Comment
Vigorito, Afonso Celso
Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
title Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
title_full Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
title_fullStr Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
title_full_unstemmed Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
title_short Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
title_sort hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
topic Scientific Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119658/
https://www.ncbi.nlm.nih.gov/pubmed/27863752
http://dx.doi.org/10.1016/j.bjhh.2016.07.006
work_keys_str_mv AT vigoritoafonsocelso hematopoieticstemcellmobilizationforautologoustransplantationinmultiplemyelomapatientspreviouslyexposedtocyclophosphamidethalidomideanddexamethasoneisgranulocytecolonystimulatingfactoraloneenough